ZOM — Zomedica Cashflow Statement
0.000.00%
Last trade - 00:00
- $133.37m
- $42.87m
- $25.19m
- 36
- 40
- 32
- 29
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -19.8 | -16.9 | -18.4 | -17 | -34.5 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 3.33 | 1.86 | 6.84 | 7.01 | 13.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.03 | -1.72 | -1.35 | -3.35 | -0.161 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -15.6 | -16.2 | -14.3 | -11.7 | -16 |
Capital Expenditures | -0.687 | -0.017 | -0.526 | -2.79 | -15.5 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 1.02 | -71.4 | -153 | 17.1 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.687 | 1.01 | -71.9 | -156 | 1.58 |
Financing Cash Flow Items | 2.29 | -5.11 | -14.3 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.9 | 76.7 | 219 | 0.008 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.43 | 61.5 | 133 | -168 | -14.4 |